Volume 16, Issue 5 | CNS Drugs

Home
CNS Drugs
Volumes and issues
Volume 16, Issue 5

CNS Drugs

Publishing model:: Hybrid

Submit your manuscript

Search all CNS Drugs articles

Volume 16, Issue 5

May 2002

Filter by

Volume:

Sort by

Date published:

New to old Old to new

8 articles in this issue

Pros and Cons for the Development of New Antiepileptic Drugs
Meir Bialer
Matthew C. Walker
Josemir W. Sander
Current Opinion 14 September 2012 Pages: 285 - 289
Mood Disorders in Patients with Epilepsy
Cynthia L. Harden
Martin A. Goldstein
Therapy In Practice 14 September 2012 Pages: 291 - 302
CNS Manifestations of Cytomegalovirus Infections
Matthias Maschke
Oliver Kastrup
Hans-Christoph Diener
Therapy In Practice 14 September 2012 Pages: 303 - 315
Genetic Predictors of Therapeutic Response to Clozapine
Dalu Mancama
Maria J. Arranz
Robert W. Kerwin
Review Article 14 September 2012 Pages: 317 - 324
Brain Metastases
Phillip Davey
Review Article 14 September 2012 Pages: 325 - 338
The Role of Iron and Copper in the Aetiology of Neurodegenerative Disorders
George Perry
Lawrence M. Sayre
Mark A. Smith
Review Article 14 September 2012 Pages: 339 - 352
Potential Savings from Splitting Newer Antidepressant Medications
Carl I. Cohen
Sara I. Cohen
Original Research Article 14 September 2012 Pages: 353 - 358
Splitting Antidepressant Medications
John Donoghue
Commentary 14 September 2012 Pages: 359 - 360